Relay Therapeutics CEO Sanjiv Patel sells $943,736 in company stock

nl.investing.com (Dutch)

Relay Therapeutics CEO Sanjiv Patel sold company stock valued at $943,736 on July 7, 2026. The sale involved 48,199 shares at an average price of $19.58, executed under a pre-arranged trading plan. This occurs as the stock nears its 52-week high after a significant annual increase. Patel also acquired shares earlier in July. The company recently announced a public offering to raise approximately $275 million for its clinical trials and drug development efforts.


With a significance score of 1.1, this news ranks in the top 56% of today's 33018 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Relay Therapeutics CEO Sanjiv Patel sells $943,736 in company stock | News Minimalist